Chemoinformaics analysis of 6-Octadecenyl 3-methylbutanoate
| Molecular Weight | 354.619 | nRot | 19 |
| Heavy Atom Molecular Weight | 308.251 | nRig | 1 |
| Exact Molecular Weight | 354.35 | nRing | 0 |
| Solubility: LogS | -7.295 | nHRing | 0 |
| Solubility: LogP | 9.385 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 70.6865 |
| nHD | 0 | BPOL | 48.7515 |
| QED | 0.174 |
| Synth | 2.018 |
| Natural Product Likeliness | 0.228 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.941 |
| MDCK | 0.0000105 |
| BBB | 0.067 |
| PPB | 0.969896 |
| VDSS | 2.749 |
| FU | 0.0165109 |
| CYP1A2-inh | 0.096 |
| CYP1A2-sub | 0.166 |
| CYP2c19-inh | 0.316 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.105 |
| CYP2c9-sub | 0.968 |
| CYP2d6-inh | 0.072 |
| CYP2d6-sub | 0.016 |
| CYP3a4-inh | 0.23 |
| CYP3a4-sub | 0.048 |
| CL | 5.792 |
| T12 | 0.085 |
| hERG | 0.328 |
| Ames | 0.003 |
| ROA | 0.023 |
| SkinSen | 0.967 |
| Carcinogencity | 0.045 |
| EI | 0.96 |
| Respiratory | 0.785 |
| NR-Aromatase | 0.049 |
| Antiviral | Yes |
| Prediction | 0.562023 |